BIO-TECHNE CORP (TECH) Fundamental Analysis & Valuation
NASDAQ:TECH • US09073M1045
Current stock price
53.13 USD
-0.35 (-0.65%)
At close:
53.13 USD
0 (0%)
After Hours:
This TECH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. TECH Profitability Analysis
1.1 Basic Checks
- TECH had positive earnings in the past year.
- TECH had a positive operating cash flow in the past year.
- In the past 5 years TECH has always been profitable.
- In the past 5 years TECH always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of TECH (3.17%) is better than 75.00% of its industry peers.
- With a decent Return On Equity value of 3.98%, TECH is doing good in the industry, outperforming 75.00% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 9.52%, TECH belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for TECH is below the industry average of 11.80%.
- The last Return On Invested Capital (9.52%) for TECH is above the 3 year average (9.00%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROIC | 9.52% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
1.3 Margins
- TECH's Profit Margin of 6.58% is fine compared to the rest of the industry. TECH outperforms 69.64% of its industry peers.
- In the last couple of years the Profit Margin of TECH has declined.
- With an excellent Operating Margin value of 22.59%, TECH belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
- In the last couple of years the Operating Margin of TECH has remained more or less at the same level.
- TECH has a Gross Margin of 66.60%. This is amongst the best in the industry. TECH outperforms 87.50% of its industry peers.
- In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% |
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
2. TECH Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TECH is destroying value.
- TECH has less shares outstanding than it did 1 year ago.
- TECH has more shares outstanding than it did 5 years ago.
- TECH has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 11.44 indicates that TECH is not in any danger for bankruptcy at the moment.
- TECH's Altman-Z score of 11.44 is amongst the best of the industry. TECH outperforms 96.43% of its industry peers.
- TECH has a debt to FCF ratio of 1.17. This is a very positive value and a sign of high solvency as it would only need 1.17 years to pay back of all of its debts.
- The Debt to FCF ratio of TECH (1.17) is better than 91.07% of its industry peers.
- TECH has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
- TECH has a better Debt to Equity ratio (0.13) than 60.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Altman-Z | 11.44 |
ROIC/WACC0.87
WACC10.89%
2.3 Liquidity
- A Current Ratio of 4.54 indicates that TECH has no problem at all paying its short term obligations.
- The Current ratio of TECH (4.54) is better than 75.00% of its industry peers.
- TECH has a Quick Ratio of 3.08. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
- TECH has a better Quick ratio (3.08) than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 |
3. TECH Growth Analysis
3.1 Past
- TECH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.84%, which is quite good.
- TECH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.25% yearly.
- Looking at the last year, TECH shows a small growth in Revenue. The Revenue has grown by 1.64% in the last year.
- The Revenue has been growing by 10.55% on average over the past years. This is quite good.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
3.2 Future
- TECH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.61% yearly.
- TECH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.10% yearly.
EPS Next Y5.04%
EPS Next 2Y7.37%
EPS Next 3Y10.09%
EPS Next 5Y8.61%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.54%
Revenue Next 5Y7.1%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. TECH Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 26.97, TECH can be considered very expensive at the moment.
- 71.43% of the companies in the same industry are more expensive than TECH, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of TECH to the average of the S&P500 Index (25.60), we can say TECH is valued inline with the index average.
- With a Price/Forward Earnings ratio of 23.88, TECH is valued on the expensive side.
- 71.43% of the companies in the same industry are more expensive than TECH, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 22.84. TECH is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.97 | ||
| Fwd PE | 23.88 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 66.07% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 66.07% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.27 | ||
| EV/EBITDA | 22.2 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of TECH may justify a higher PE ratio.
PEG (NY)5.35
PEG (5Y)2.4
EPS Next 2Y7.37%
EPS Next 3Y10.09%
5. TECH Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.61%, TECH is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.11, TECH pays a better dividend. On top of this TECH pays more dividend than 92.86% of the companies listed in the same industry.
- With a Dividend Yield of 0.61, TECH pays less dividend than the S&P500 average, which is at 1.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
- The dividend of TECH has a limited annual growth rate of 0.11%.
- TECH has been paying a dividend for at least 10 years, so it has a reliable track record.
- TECH has decreased its dividend recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
- TECH pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of TECH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.38%
EPS Next 2Y7.37%
EPS Next 3Y10.09%
TECH Fundamentals: All Metrics, Ratios and Statistics
53.13
-0.35 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-05 2026-05-05/bmo
Inst Owners113.95%
Inst Owner Change4.01%
Ins Owners0.25%
Ins Owner Change1.57%
Market Cap8.31B
Revenue(TTM)1.22B
Net Income(TTM)79.96M
Analysts80.87
Price Target76.73 (44.42%)
Short Float %7.92%
Short Ratio5.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP62.38%
Div Incr Years0
Div Non Decr Years1
Ex-Date02-13 2026-02-13 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.96%
Min EPS beat(2)-2.04%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)6
Avg EPS beat(8)3.61%
EPS beat(12)6
Avg EPS beat(12)1.11%
EPS beat(16)7
Avg EPS beat(16)-2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)-0.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)4
Avg Revenue beat(16)-2.17%
PT rev (1m)7.39%
PT rev (3m)7.67%
EPS NQ rev (1m)-0.57%
EPS NQ rev (3m)-4.65%
EPS NY rev (1m)0.37%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.97 | ||
| Fwd PE | 23.88 | ||
| P/S | 6.84 | ||
| P/FCF | 37.27 | ||
| P/OCF | 33.34 | ||
| P/B | 4.13 | ||
| P/tB | 11.95 | ||
| EV/EBITDA | 22.2 |
EPS(TTM)1.97
EY3.71%
EPS(NY)2.23
Fwd EY4.19%
FCF(TTM)1.43
FCFY2.68%
OCF(TTM)1.59
OCFY3%
SpS7.77
BVpS12.85
TBVpS4.45
PEG (NY)5.35
PEG (5Y)2.4
Graham Number23.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROCE | 11.53% | ||
| ROIC | 9.52% | ||
| ROICexc | 10.26% | ||
| ROICexgc | 25.36% | ||
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% | ||
| FCFM | 18.35% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score8
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Debt/EBITDA | 0.69 | ||
| Cap/Depr | 25.35% | ||
| Cap/Sales | 2.16% | ||
| Interest Coverage | 15.32 | ||
| Cash Conversion | 65.89% | ||
| Profit Quality | 278.92% | ||
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 | ||
| Altman-Z | 11.44 |
F-Score8
WACC10.89%
ROIC/WACC0.87
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y5.04%
EPS Next 2Y7.37%
EPS Next 3Y10.09%
EPS Next 5Y8.61%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.54%
Revenue Next 5Y7.1%
EBIT growth 1Y9.53%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year16.56%
EBIT Next 3Y11.92%
EBIT Next 5Y8.56%
FCF growth 1Y-1.07%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-9.8%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%
BIO-TECHNE CORP / TECH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
What is the valuation status of BIO-TECHNE CORP (TECH) stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.
Can you provide the profitability details for BIO-TECHNE CORP?
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
Can you provide the financial health for TECH stock?
The financial health rating of BIO-TECHNE CORP (TECH) is 8 / 10.
What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?
The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 5.04% in the next year.